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Abstract
Background: Sarcoidosis is a systemic granulomatous disease caused by CD4+ cell-dominant inflammation. Meanwhile,
diffuse panbronchiolitis is a chronic inflammatory respiratory disease predominantly caused by CD8+ lymphocytes and
neutrophils. Herein, we report a rare case of sarcoidosis in which the clinical presentation had become evident as diffuse
panbronchiolitis after splenectomy for sarcoidosis.
Case presentation: A 23-year-old Japanese woman was referred to our hospital due to splenomegaly of unknown etiology.
Upon admission, chest computed tomography scan revealed centrilobular and randomly distributed small nodules in both
lungs. Bronchoalveolar lavage revealed a high proportion of lymphocytes and a decreased CD4/CD8 ratio. However, the
biopsy specimens obtained from both the liver and lungs revealed noncaseating epithelioid granulomas, which confirmed
the diagnosis of sarcoidosis. The patient underwent splenectomy due to progressive cytopenia and high risk of splenic
rupture. After the surgery, the condition of the patient was consistently good for 3months. Then, she gradually developed
productive cough and dyspnea. Both sinus and chest computed tomography scan revealed chronic paranasal sinusitis and
deterioration of centrilobular nodules in both lung fields, respectively. The second bronchoalveolar lavage revealed a high
proportion of neutrophils, and the bronchoalveolar lavage fluid tested positive for Hemophilus influenzae. The titer of cold
agglutinin was elevated, thereby confirming the diagnosis of diffuse panbronchiolitis. On the basis of the clinical and
radiological findings, the condition of the patient improved with low-dose macrolide therapy for 3months.
Conclusions: The coexistence of sarcoidosis and diffuse panbronchiolitis has not been previously reported, and the hidden
profiles of diffuse panbronchiolitis may have been revealed by splenectomy.
Keywords: Sarcoidosis, Diffuse panbronchiolitis, Splenectomy, CD4/CD8 ratio
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: takeyama.kiyoshi@twmu.ac.jp
1Department of Respiratory Medicine, Tokyo Women’s Medical University
School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
Full list of author information is available at the end of the article
Akaba et al. BMC Pulmonary Medicine           (2020) 20:77 
https://doi.org/10.1186/s12890-020-1117-y
Background
Sarcoidosis is a systemic granulomatous disease of un-
known etiology. The lungs and intrathoracic lymph nodes
are the commonly affected regions, and the liver and
spleen are the most commonly affected extrapulmonary
organs [1, 2]. A high proportion of lymphocytes and an el-
evated CD4+ to CD8+ T-lymphocyte ratio (CD4/CD8 ra-
tio) in the bronchoalveolar lavage (BAL) fluid (BALF)
indicate CD4+ cell-dominant inflammation in sarcoidosis.
Radiological findings of the lungs revealed various pat-
terns, such as bilateral hilar lymphadenopathy, presence of
perilymphatic or centrilobular small nodules, and nodular
thickening along the lymphatic vessels in the bronchovas-
cular bundle [3]. Therefore, the differential diagnosis for
sarcoidosis is broad and distinguishing the condition from
other respiratory diseases is sometimes challenging.
Meanwhile, diffuse panbronchiolitis (DPB) is a chronic
inflammatory respiratory disease predominantly affecting
East Asians [4]. The typical pathological features are ob-
served in the respiratory bronchioles, which include
peribronchial infiltration of foamy histiocytes, neutro-
phils, and CD8+ lymphocytes. Chest computed tomog-
raphy (CT) scan revealed centrilobular nodules and
bronchial wall thickening, indicating chronic neutro-
philic inflammation caused by Hemophilus influenzae or
Pseudomonas aeruginosa.
Fig. 1 a Chest computed tomography (CT) scan revealed the presence of centrilobular nodules in the lung parenchyma. b Abdominal CT scan
revealed the remarkable enlargement of the spleen. c The first analysis of the bronchoalveolar lavage fluid revealed a high proportion of small lymphocytes
Table 1 Cell count in the first bronchoalveolar lavage fluid
BALF findings Criterion value
total cell (/mL) 2.6 × 10*5 0.5 × 10*5 ~ 2.0 × 10*5
macrophage (%) 22.7 80 ~ 94
lymphocyte (%) 69.9 5.0 ~ 18
neutrophil (%) 5.8 0 ~ 2.0
eosinophil (%) 1.3 0 ~ 1.0
basophil (%) 0 0
mast cell (%) 0.3 0
CD4/CD8 ratio 0.12 1.0 ~ 2.0
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The mechanisms of these two respiratory diseases are
different, and the coexistence of sarcoidosis and DPB
has not been observed in previous studies. Herein, we
report a case of sarcoidosis in which the clinical presen-
tation had become evident as DPB after splenectomy for
sarcoidosis.
Case presentation
A 23-year-old Japanese woman was referred to our hos-
pital due to splenomegaly of unknown etiology and cyto-
penia. Before referral, she underwent intensive
examinations, including bone marrow aspiration and
spleen biopsy, at other medical care centers for the
detection of hematologic, endocrine, and hereditary dis-
eases in a differential diagnosis. However, a definitive
diagnosis was not made. Upon admission, the patient
presented with dyspnea upon exertion and abdominal
distention. Chest CT scan revealed the presence of both
centrilobular and randomly distributed small nodules in
both lungs (Fig. 1a). In addition, abdominal CT scan re-
vealed splenomegaly (Fig. 1b). Lung function test upon
admission revealed restrictive ventilatory impairment
with reduced pulmonary diffusion capacity. Liver biopsy
was performed, and the biopsy specimen revealed a non-
caseating granuloma, indicating sarcoidosis. Then, the
patient underwent transbronchial lung biopsy and BAL
to evaluate for lung involvement. Although an increased
number of small lymphocytes in the BALF, which is a
typical finding, was observed, the CD4/CD8 ratio de-
creased to 0.12 (Fig. 1c and Table 1). Moreover, the bi-
opsy specimen from the lung showed noncaseating
epithelioid granuloma positively stained with CD68 in
the lung interstitium (Fig. 2a, b). The tuberculin reaction
test had a negative finding. On the basis of these results
and the elevated level of angiotensin-converting enzyme
(ACE) (45.1 U/L), lysozyme (36.4 μg/mL), and serum sol-
uble interleukin-2 receptor (5290 U/mL), the diagnosis
of sarcoidosis was confirmed (Table 2). Because of pro-
gressive cytopenia and high risk of splenic rupture,
splenectomy was chosen as the initial therapy. The
pathological findings of the resected spleen revealed
noncaseating granuloma, which was consistent with the
Fig. 2 a The biopsy specimen from the lung showed noncaseating granuloma with accumulation of epithelioid cells (white arrow). b Immunohistological
staining of the biopsy specimen revealed the presence of CD68-positive cells, which represented epithelioid cells (black arrow). c The resected spleen had diffusely
scattered noncaseating epithelioid granulomas (white arrow). d CD68-positive cells were observed in the scattered granuloma region (black arrow). e Foamy cells
infiltrating the interstitial wall were observed around the respiratory bronchiole (black arrowhead)
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splenic lesion in sarcoidosis (Figs. 2c, d). Along with the
decrease in the level of serum ACE (24.1 U/L) and lyso-
zyme (22.4 μg/mL), dyspnea and abdominal distention
improved after splenectomy (Table 3).
The patient complained of gradually exacerbating dys-
pnea and increase in purulent sputum 3months after
splenectomy. Chest CT scan revealed the presence of
centrilobular nodules with bronchial wall thickening in
both lung fields (Fig. 3a). The second BAL revealed a re-
markable increase in neutrophil count (Fig. 3b, Table 4).
The bacterial culture from the BALF tested positive for
Hemophilus influenzae. In addition, the cold agglutinin
test had positive results, and paranasal sinus CT scan re-
vealed inflammation of the maxillary sinus (Fig. 3c). Be-
cause these data showed the characteristics of DPB, we
re-evaluated the lung biopsy specimen obtained during
the first bronchoscopy. The foamy cells infiltrating the
interstitial wall surrounding a respiratory bronchiole
supported the diagnosis of DPB (Fig. 2e). Because DPB
primarily caused the patient’s current symptoms and
radiological deterioration, 600mg of erythromycin was
administered daily as the initial treatment. After admin-
istrating low-dose macrolide therapy for 3 months, the
patient’s condition improved based on the clinical and
radiological findings (Fig. 4).
Discussion and conclusions
Herein, we report the coexistence of sarcoidosis and
DPB, which became evident after splenectomy. The
diagnosis of sarcoidosis was confirmed on the basis of
the presence of noncaseating granulomas in the biopsy
specimens obtained from several organs, including the
liver, spleen, and lungs. Increased lymphocyte count in
the BALF is commonly observed in patients with sar-
coidosis; the CD4+ lymphocytes infiltrate into the al-
veoli, causing the high CD4/CD8 ratio in the BALF [1,
2]. However, the CD4/CD8 ratio in the BALF in the
present case was low (0.12), which was not consistent
with sarcoidosis. A CD4/CD8 ratio < 1 is observed in
12% of patients with sarcoidosis confirmed via biopsy
[5]. However, the cause of CD8+ lymphocyte predomin-
ance in sarcoidosis is not completely understood. In the
present case, DPB might have affected the CD4/CD8 ra-
tio in the BALF. Because neutrophils and CD8+ lympho-
cytes play a role in the development of DPB, the
migration of CD8+ lymphocytes into the alveoli might
have resulted in a low CD4/CD8 ratio in the BALF [6].
Splenectomy might have triggered the exacerbation of
DPB. The levels of serum ACE and lysozyme, which re-
flect the disease activity of sarcoidosis, decreased after
splenectomy. By contrast, the presence of centrilobular
nodules, which is one of the radiological features of
DPB, was found on chest CT scan in the current case.
Furthermore, the second BAL revealed both increased
proportion of neutrophils and a positive bacterial culture
for Hemophilus influenzae. Since splenectomy is a risk
factor for infectious diseases caused by Hemophilus in-
fluenza, it may explain the exacerbation in DPB.
In the present case, the histological features of DPB
were also confirmed; biopsy specimens obtained during
the first bronchoscopy showed accumulation of foamy
cells around the respiratory bronchioles where the dis-
tinctive feature is observed in patients with DPB [7]. The
deterioration of bronchiolitis was successfully treated
with a low-dose macrolide therapy. Similarly, a sarcoid-
osis case that diagnosed during the clinical course of
Table 3 Blood test result after splenectomy
Laboratory findings Criterion value
ACE (U/L) 24.1 7.0 ~ 25.0
lysozyme (μg/mL) 22.4 3.4 ~ 8.6
sIL-2R (U/mL) 4114 120 ~ 500
HTLV-1 negative negative
HIV negative negative
cold agglutinin test (titer) 256 4 ~ 64
Table 2 Blood test results upon admission
Laboratory findings Criterion value
WBC (/μL) 1760 4000 ~ 8600
Neu (%) 61.3 38 ~ 70
Lymp (%) 23.9 27 ~ 45
Mono (%) 11.9 0 ~ 7
Eosino (%) 2.3 0 ~ 2
RBC (/μL) 4.22 × 10*6 3.80 × 10*6 ~ 4.80 × 10*6
Hb (g/dL) 11.1 12.0 ~ 16.0
Hct (%) 35.9 35.0 ~ 43.0
Plt (/μL) 6.5 × 10*4 15.0 × 10*4 ~ 35.0 × 10*4
TP (g/dL) 7.5 6.5 ~ 8.2
Alb (g/dL) 4.1 3.8 ~ 5.1
T-Bil (mg/dL) 0.9 0.2 ~ 1.2
AST (U/L) 45 13 ~ 33
ALT (U/L) 25 6 ~ 31
LDH (U/L) 188 119 ~ 229
ALP (U/L) 557 115 ~ 359
γ-GTP (U/L) 64 6 ~ 46
Cr (mg/dL) 0.88 0.48 ~ 0.79
BUN (mg/dL) 8.0 8.0 ~ 20.0
CRP (mg/dL) 0.73 0 ~ 0.30
ACE (U/L) 45.1 7.0 ~ 25.0
Lysozyme (μg/mL) 36.4 3.4 ~ 8.6
KL-6 (U/mL) 1134 < 500
sIL-2R (U/mL) 5290 120 ~ 500
T-SPOT negative negative
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Fig. 3 a Chest computed tomography (CT) scan revealed bronchial wall thickening and presence of centrilobular nodules 3 months after
splenectomy. b The second analysis of the bronchoalveolar lavage fluid revealed a remarkable increase in neutrophil count. c Paranasal sinus CT
scan revealed thickening of the maxillary sinus wall
Table 4 Cell count in the second bronchoalveolar lavage fluid
BALF findings Criterion value
total cell (/mL) 2.3 × 10*5 0.5 × 10*5 ~ 2.0 × 10*5
macrophage (%) 0.7 80 ~ 94
lymphocyte (%) 5.3 5.0 ~ 18
neutrophil (%) 94 0 ~ 2.0
eosinophil (%) 0 0 ~ 1.0
basophil (%) 0 0
mast cell (%) 0 0
CD4/CD8 ratio 0.09 1.0 ~ 2.0
Fig. 4 The pattern of centrilobular nodules slightly improved after
the initiation of macrolide therapy
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idiopathic bronchiolitis mimicking DPB was improved
by erythromycin [8].
In conclusion, the present case highlighted the com-
plex presentation of the coexistence of sarcoidosis and
DPB. If a patient with sarcoidosis presents with an atyp-
ical disease presentation, the coexistence of other dis-
eases should be considered.
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